DDAVPRhinal Tube (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the DDAVP drug offered from sanofi-aventis U.S. LLC. This Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | Desmopressin Acetate |
SUBSTANCE NAME: | DESMOPRESSIN ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |
ROUTE: | NASAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1978-02-21 |
END MARKETING DATE: | 0000-00-00 |
DDAVP Rhinal Tube HUMAN PRESCRIPTION DRUG Details:
Item Description | DDAVP Rhinal Tube from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.1(mg/mL) |
START MARKETING DATE: | 1978-02-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0075-2450_b1b1e14c-afba-44c1-a384-5aae6a624046 |
PRODUCT NDC: | 0075-2450 |
APPLICATION NUMBER: | NDA017922 |
Other DESMOPRESSIN ACETATE Pharmaceutical Manufacturers / Labelers: